IL1B and gastric cancer: Consistently, cisplatin or LncRNA ADAMTS9 overexpression alone had little effects on caspase-1 activity (Figure 7E), IL-1β (Figure 7F) and IL-18 (Figure 7G) expressions in CR-GC cells and their supernatants, which were promoted by cisplatin plus LncRNA ADAMTS9 overexpression treatment.